KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 103 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q1 2014. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $35,000 | -25.5% | 468 | -24.5% | 0.00% | – |
| Q2 2015 | $47,000 | +104.3% | 620 | +37.8% | 0.00% | – |
| Q1 2015 | $23,000 | +43.8% | 450 | 0.0% | 0.00% | – |
| Q4 2014 | $16,000 | +23.1% | 450 | +10.8% | 0.00% | – |
| Q3 2014 | $13,000 | -18.8% | 406 | 0.0% | 0.00% | – |
| Q2 2014 | $16,000 | +45.5% | 406 | +48.2% | 0.00% | – |
| Q1 2014 | $11,000 | +10.0% | 274 | 0.0% | 0.00% | – |
| Q4 2013 | $10,000 | -16.7% | 274 | 0.0% | 0.00% | – |
| Q3 2013 | $12,000 | +71.4% | 274 | 0.0% | 0.00% | – |
| Q2 2013 | $7,000 | – | 274 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AlpInvest Partners B.V. | 48,087 | $1,668,000 | 4.13% |
| Versant Venture Management, LLC | 70,376 | $2,440,640,000 | 2.33% |
| Palo Alto Investors LP | 1,121,884 | $38,907,000 | 2.28% |
| Aureus Asset Management, LLC | 124,087 | $4,303,000 | 1.05% |
| PFM Health Sciences, LP | 1,085,315 | $37,639,000 | 0.88% |
| HARBOURVEST PARTNERS LLC | 39,318 | $1,364,000 | 0.72% |
| REGENTATLANTIC CAPITAL LLC | 176,454 | $6,119,425,000 | 0.52% |
| Partner Investment Management, L.P. | 24,456 | $848,000 | 0.35% |
| Old West Investment Management, LLC | 15,162 | $525,000 | 0.32% |
| Polar Capital LLP | 405,544 | $14,063,000 | 0.27% |